Prevalence of human immunodeficiency virus, hepatitis b,c, and syphilis among healthy donors attending blood bank unit at kosti teaching hospital, white Nile state, august - October 2022
Elham Elamin, Abdalmoneim M Magboul, Osama A Abd Elmwla, Hind Abd Almoula, Amani MA Alhassan, Najat A Awooda, Shimaa SE Andli
{"title":"Prevalence of human immunodeficiency virus, hepatitis b,c, and syphilis among healthy donors attending blood bank unit at kosti teaching hospital, white Nile state, august - October 2022","authors":"Elham Elamin, Abdalmoneim M Magboul, Osama A Abd Elmwla, Hind Abd Almoula, Amani MA Alhassan, Najat A Awooda, Shimaa SE Andli","doi":"10.15406/htij.2023.11.00302","DOIUrl":null,"url":null,"abstract":"This descriptive observation study design was carried out in Blood Bank unit in Kosti Teaching Hospital, during the period of August first through 30 October 2022; included 600 donor all are male aged was ranged between 19-48 years were enrolled in this study. Our study aimed to evaluate the prevalence of routine screening tests [human immunodeficiency virus {HIV], hepatitis B, C, and syphilis], among blood donors. Venous blood samples were collected from each donor tested by immune- Chromatography Test [ICT], the data were analyzed using statistical packed for social sciences [SPSS] software version 26. Our results showed that [0.17%] of samples collected was HIV positive {+ve}, HBsAg, [07.17%], HCV [2%], and syphilis [06.44%]. The frequency of HIV, HBs Ag, HCV, and Syphilis in donors, according to donation time [87%] for the first, [12% [, second, and [1%] for the third time, HIV, HBs Ag, HCV, and Syphilis in donor’s positive case [+ve] according to ABO blood group type , one donor group [AB+ve], HBs Ag equal [43%] donors, [26%] group [O+ve], 14 [A+ve], 2 [B+ve], and one donor group [AB+ve], HCV [12%], group, 9 [O+ve], 2 [A+ve] and one donor [ B+ve], and Syphilis, 41 donors , 29 group [O+ve] , 10 [A+ve and 2 donors [B+ve] . The blood transfusion services based on the voluntary non-paid donation; besides, the effective central to promote, protect the health of blood donors, and the recipients of blood or blood products.","PeriodicalId":475111,"journal":{"name":"Hematology & Transfusion International Journal","volume":"21 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology & Transfusion International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/htij.2023.11.00302","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This descriptive observation study design was carried out in Blood Bank unit in Kosti Teaching Hospital, during the period of August first through 30 October 2022; included 600 donor all are male aged was ranged between 19-48 years were enrolled in this study. Our study aimed to evaluate the prevalence of routine screening tests [human immunodeficiency virus {HIV], hepatitis B, C, and syphilis], among blood donors. Venous blood samples were collected from each donor tested by immune- Chromatography Test [ICT], the data were analyzed using statistical packed for social sciences [SPSS] software version 26. Our results showed that [0.17%] of samples collected was HIV positive {+ve}, HBsAg, [07.17%], HCV [2%], and syphilis [06.44%]. The frequency of HIV, HBs Ag, HCV, and Syphilis in donors, according to donation time [87%] for the first, [12% [, second, and [1%] for the third time, HIV, HBs Ag, HCV, and Syphilis in donor’s positive case [+ve] according to ABO blood group type , one donor group [AB+ve], HBs Ag equal [43%] donors, [26%] group [O+ve], 14 [A+ve], 2 [B+ve], and one donor group [AB+ve], HCV [12%], group, 9 [O+ve], 2 [A+ve] and one donor [ B+ve], and Syphilis, 41 donors , 29 group [O+ve] , 10 [A+ve and 2 donors [B+ve] . The blood transfusion services based on the voluntary non-paid donation; besides, the effective central to promote, protect the health of blood donors, and the recipients of blood or blood products.